Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma
| Conditions: | Pleural Neoplasms |
| Start Date: | September 1, 2003 |
| Phase: | Phase II |
| Status: | Completed |
| NCT ID: | NCT00087698 |
| Study Type: | Interventional |
| Intervention: | Drug: pemetrexed|Drug: cisplatin |
| Study Design: | Allocation: Non-Randomized|Control: Uncontrolled|Endpoint Classification: Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | Has Results |
| Sponsors: | Eli Lilly and Company |
| Ages: | Adult|Senior |
| Enrollment: | 77 |
| Funded By: | Industry |
| First Received: | July 12, 2004 |
| End Date: | February 1, 2008 |
| Last Updated: | May 1, 2009 |
| Last Verified: | May 1, 2009 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
